Celldex Therapeutics, Inc. (CLDX) has a consensus analyst rating of Buy, based on 19 analysts covering the stock. Of those, 15 recommend buying, 3 recommend holding, and 1 recommend selling.
The analyst consensus price target for CLDX is $24.00, representing a -28.0% downside from the current price of $33.33. Price targets range from a low of $24.00 to a high of $24.00.
